November 10, 2003
Nippon Shinyaku Licenses Overactive Bladder Agent to Apogepha of Germany Nippon Shinyaku announced on November 4 that it formed an license agreement on October 30 with Apogepha Artzneimittel GmbH in Dresden, Germany for granting it to exclusively develop and market...read more